benzoxazoles has been researched along with Dermatitis, Atopic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Anzai, N; Endou, H; Fujita, T; Hayashi, K; Hiroi, T; Iwata, Y; Jutabha, P; Kaminuma, O; Kanai, Y; Kurasawa, K; Matsuoka, K; Nishimura, T; Okayasu, I; Ouchi, M; Owada, T; Saeki, M; Sugiura, K | 1 |
| Abels, C; Ahrens, K; Marsella, R; Massre, D; Sanford, R; Soeberdt, M; Trujillo, A | 1 |
| Imada, T; Kobayashi, F; Komorita, N; Kondo, T; Miyazaki, M; Naito, K; Nakamura, N; Yoshikawa, T | 1 |
3 other study(ies) available for benzoxazoles and Dermatitis, Atopic
| Article | Year |
|---|---|
LAT1-specific inhibitor is effective against T cell-mediated allergic skin inflammation.
Topics: Amino Acid Transport System y+L; Animals; Benzoxazoles; CD4-Positive T-Lymphocytes; Cells, Cultured; Dermatitis, Atopic; Disease Models, Animal; Humans; Large Neutral Amino Acid-Transporter 1; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Knockout; Signal Transduction; Th2 Cells; Treatment Outcome; Tyrosine | 2020 |
Double blinded, vehicle controlled, crossover study on the efficacy of a topical endocannabinoid membrane transporter inhibitor in atopic Beagles.
Topics: Administration, Topical; Animals; Benzoxazoles; Cross-Over Studies; Dermatitis, Atopic; Disease Models, Animal; Dogs; Double-Blind Method; Endocannabinoids; Female; Gels; Male; Membrane Transport Modulators; Membrane Transport Proteins; Pruritus; Pyroglyphidae; Severity of Illness Index; Skin; Treatment Outcome | 2019 |
Therapeutic potential of a specific chymase inhibitor in atopic dermatitis.
Topics: Acetamides; Administration, Oral; Animals; Antipruritics; Behavior, Animal; Benzoxazoles; Chymases; Dermatitis, Atopic; Disease Models, Animal; Dose-Response Relationship, Drug; Immunoglobulin E; Mice; Pruritus; Rats; Serine Endopeptidases; Serine Proteinase Inhibitors | 2002 |